Vanguard Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.5M | Sell |
|
|||||
|
2025
Q2 | $22.7M | Sell |
|
|||||
|
2025
Q1 | $23M | Buy |
|
|||||
|
2024
Q4 | $35.8M | Sell |
|
|||||
|
2024
Q3 | $50.2M | Buy |
|
|||||
|
2024
Q2 | $50.1M | Buy |
|
|||||
|
2024
Q1 | $30.2M | Buy |
|
|||||
|
2023
Q4 | $18.1M | Buy |
|
|||||
|
2023
Q3 | $15.3M | Sell |
|
|||||
|
2023
Q2 | $21.8M | Sell |
|
|||||
|
2023
Q1 | $26.1M | Sell |
|
|||||
|
2022
Q4 | $29.7M | Buy |
|
|||||
|
2022
Q3 | $35.4M | Buy |
|
|||||
|
2022
Q2 | $35.2M | Buy |
|
|||||
|
2022
Q1 | $24.6M | Sell |
|
|||||
|
2021
Q4 | $36.5M | Buy |
|
|||||
|
2021
Q3 | $51.5M | Buy |
|
|||||
|
2021
Q2 | $29.8M | Buy |
|
|||||
|
2021
Q1 | $48M | Buy |
|